Literature DB >> 8546026

Alzheimer's disease-type neurofibrillary degeneration in verrucose dysplasias of the cerebral cortex.

M A Morán1, A Probst, C Navarro, P Gómez-Ramos.   

Abstract

Verrucose dysplasias, found at autopsy in the cerebral cortex of three elderly individuals (two without neurological disorders and one with motor neuron disease), are shown to present neurofibrillary degeneration of Alzheimer's disease type. This neurofibrillary degeneration immunoreacted with antibodies against abnormally phosphorylated tau (5E2 and AT8), disclosed acetyl- and butyrylcholinesterase activity, and was consistently stained with thioflavin-S. Cortical dysplasias, found either as isolated verrucose nodules or comprising multiple nodules, contained cell-sparse areas around which a peak of neurofibrillary changes was seen. Cell-sparse areas were sometimes bridged by stripes of neurons and fibers arranged in a radial fashion, and many of these neurons showed neurofibrillary degeneration. Cytoskeletal abnormalities were conspicuous in layers II and III at the external borders of the dysplasias, as well as in neurons located in layers V and VI, and in the white matter beneath layer VI in central zones of each lesion. The morphology of cells undergoing neurofibrillary changes (from early non-fibrillar stages to late extracellular ones) suggests that neurons disturbed in their migration toward the site to which they had been committed may become vulnerable to cytoskeletal changes. Micro-environmental disturbances related to hypoxia-ischemia in the affected cortex are proposed as likely contributing factors for the long-term production of this neurofibrillary degeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546026     DOI: 10.1007/bf00315009

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  56 in total

1.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

2.  Verrucose dysplasia of the cerebral cortex. (Dysgenesie nodulaire disseminee of Morel and Wildi).

Authors:  N GRCEVIC; F ROBERT
Journal:  J Neuropathol Exp Neurol       Date:  1961-07       Impact factor: 3.685

3.  Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.

Authors:  C L Joachim; J H Morris; D J Selkoe; K S Kosik
Journal:  J Neuropathol Exp Neurol       Date:  1987-11       Impact factor: 3.685

4.  Radial neuronal assemblies, ectopia and necrosis of developing cortex: a case analysis.

Authors:  V S Caviness; P Evrard; G Lyon
Journal:  Acta Neuropathol       Date:  1978-01-19       Impact factor: 17.088

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Origin, prenatal development and structural organization of layer I of the human cerebral (motor) cortex. A Golgi study.

Authors:  M Marin-Padilla; T M Marin-Padilla
Journal:  Anat Embryol (Berl)       Date:  1982

Review 7.  Neuronal migration, with special reference to developing human brain: a review.

Authors:  R L Sidman; P Rakic
Journal:  Brain Res       Date:  1973-11-09       Impact factor: 3.252

8.  Experimentally induced laminar necrosis, status verrucosus, focal cortical dysplasia reminiscent of microgyria, and porencephaly in the rat.

Authors:  I Ferrer; S Alcántara; I Catalá; M J Zújar
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure.

Authors:  H Tago; H Kimura; T Maeda
Journal:  J Histochem Cytochem       Date:  1986-11       Impact factor: 2.479

10.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  1 in total

Review 1.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.